bizjournals.com Health Care:Pharmaceuticals headlines This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Downtown-based Flourish Psychotherapy acquired by fast-growing Kentucky firm
Downtown Cincinnati-based Flourish Psychotherapy has been acquired by a Kentucky group as the latter firm looks to expand its footprint to the north. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 3, 2024 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news

D.C. biotech scores FDA approval for key drug, stock surges
The agency ’s nod “significantly increases the commercial opportunity” for the treatment of bipolar disorder, the company said. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 3, 2024 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

TBJ reveals 2024 Life Sciences Awards winners (Gallery)
The awards honor individuals and research organizations that are blazing trails and breaking ground across the broad spectrum of the life sciences arena. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 3, 2024 Category: Pharmaceuticals Authors: Cameron Snipes Source Type: news

New nursing school to open in Aurora
The campus is an answer to a growing need for nurses who are new to the profession. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 3, 2024 Category: Pharmaceuticals Authors: Analisa Romano Source Type: news

Prices to get high on cannabis in Arizona were lower in 2023, study reveals
Arizona saw a decrease in average wholesale cannabis pricing across the board in 2023, according to a new study. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 3, 2024 Category: Pharmaceuticals Authors: Brandon Brown Source Type: news

Dayton nonprofit takes final step in becoming an independent care provider
A Dayton nonprofit will cease operations with its longtime global partner in its efforts to become an independent clinical care provider. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 3, 2024 Category: Pharmaceuticals Authors: Lauren Steen Source Type: news

Tower Health rejoins insurance giant's provider network after brief hiatus
Two of the health system's suburban Philadelphia hospitals are also now part of the insurer's Medicare Advantage plan. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 3, 2024 Category: Pharmaceuticals Authors: John George Source Type: news

Pioneering cancer test company wants court to slow potential sale of Invitae's cancer-monitoring products
A U.S. District Court jury said last year that Invitae owed Natera close to $20 million for infringing three patents around personalized cancer monitoring. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 2, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Waukesha Memorial Hospital readies $25M NICU project for debut: Slideshow
ProHealth Care is scheduled to open its newly renovated neonatal intensive care unit April 9 at ProHealth Waukesha Memorial Hospital, which is part of a $25.7 million project. See Milwaukee Business Journal photographer Kenny Yoo ’s slideshow from a preview tour. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 2, 2024 Category: Pharmaceuticals Authors: Rich Kirchen Source Type: news

National Science Foundation supports Dayton startup with $1M in funding
The Dayton health tech startup is taking steps toward commercialization. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 2, 2024 Category: Pharmaceuticals Authors: Nicole Mistretta Source Type: news

My View: Government takeover of health care is wrong prescription for Arizona
In this guest column, former gubernatorial candidate Karrin Taylor Robson argues against any plan by the Arizona government to try to influence free market factors surrounding prescription drug costs and other facets of health care. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 2, 2024 Category: Pharmaceuticals Authors: Karrin Taylor Robson Source Type: news

$50M gift jump-starts new cancer hospital at WVU Health System
It would be built at the WVU Medicine campus in Morgantown, West Virginia. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 2, 2024 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news

Verve ’s stock tumbles as biotech pauses gene editing trial over safety concerns
Verve Therapeutics is pausing enrollment in its lead gene editing medicine and sharing its next steps. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 2, 2024 Category: Pharmaceuticals Authors: Hannah Green Source Type: news

In need of cash, longtime Bucks County biotech firm enters into merger deal
Onconova posted a net loss of $18.9 million in 2023. Since its inception, the company has an accumulated deficit of $482.6 million. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 2, 2024 Category: Pharmaceuticals Authors: John George Source Type: news

Pioneering biotech AI company Insitro CEO talks future as company extends Peninsula lease
"I don't want to count on lightning strikes," said Insitro CEO Daphne Koller. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 2, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news